March 10, 2003 (Denver) — Eight weeks of twice-daily treatment with large-particle nebulized saline (LPNS) appears to improve chronic nasal obstruction in patients dissatisfied with previous therapy, ...

There was no significant decrease in pulmonary exacerbations over 52 weeks among adults with bronchiectasis receiving hypertonic saline or carbocysteine with standard care, according to data published ...

The goal of a recent study [1] was to evaluate whether nebulized hypertonic saline (3%) was more beneficial than nebulized normal saline (0.9%) in the treatment of infants presenting to the emergency ...

Please provide your email address to receive an email when new articles are posted on . DENVER — Hypertonic saline provides no additional benefit compared with normal saline for the treatment of ...

New research shows that hospital stays for infants diagnosed with bronchiolitis, or inflammation of the lungs, and treated with nebulized 3% hypertonic saline (HS), a commonly used, off-label therapy, ...

Margaret Rosenfeld, M.D., M.P.H., of Seattle Children's Hospital, and colleagues conducted a study to examine if hypertonic saline would reduce the rate of pulmonary exacerbations in children younger ...

Abnormal homeostasis of the volume of airway surface liquid in patients with cystic fibrosis is thought to produce defects in mucus clearance and airway defense. Through osmotic forces, hypertonic ...